跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Webster Duncan
Assistant Professor
Dalhousie University
,
Energy
电子邮件
WD967900
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=18438967900
h-index
h10-index
h5-index
2378
引用
21
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
690
引用
16
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
170
引用
8
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2004
2023
每年的科研成果
综述
指纹
网络
科研成果
(69)
新闻 / 媒体
(11)
相似简介
(6)
指纹
深入其中 Webster Duncan 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Disease
92%
Serotype
85%
Respiratory Disease
69%
Influenza Vaccine
57%
Health Care Cost
52%
Frailty
51%
Pneumococcal Infection
44%
Influenza A
42%
Influenza Vaccination
41%
Opiate Agonist
40%
Mortality Rate
38%
Patient Care
37%
Opioid Abuse
34%
Community-Acquired Pneumonia
34%
Opiate
31%
Addiction Medicine
30%
Consultation
30%
Staphylococcal Pneumonia
28%
Hantavirus Pulmonary Syndrome
28%
Tonsil Cancer
28%
Case Definition
28%
Pooled Analysis
28%
Community-Based Care
28%
Informed Consent
28%
Microbiology Epidemiology
28%
Streptococcal Pharyngitis
28%
Streptococcus pyogenes
28%
Antimycobacterial
28%
Alkyne Derivative
28%
Virus Infection
28%
Q Fever
28%
Herd Immunity
28%
Primary Health Care
28%
Streptococcus equi
28%
Morphine
28%
Bullous Pemphigoid
28%
Tuberculosis Diagnosis
28%
Klebsiella oxytoca
28%
Substance Use
28%
Cannabis
28%
Mycobacterium Tuberculosis
28%
Quinolone Derivative
28%
Influenza A (H1N1)
28%
Chronic Hepatitis C
28%
Congenital Disorder of Glycosylation
28%
Mental Health
28%
Medical Record
28%
Chronic Obstructive Pulmonary Disease
28%
Masking
28%
Flu Like Syndrome
28%
Keyphrases
Q Fever
57%
Influenza
57%
Laboratory-confirmed Influenza
57%
Confidence Interval
44%
Canada
37%
Streptococcus Pneumoniae Serotype 3
28%
Diynes
28%
Antimycobacterial Activity
28%
Expression Profiling
28%
Aralia nudicaulis
28%
Case Cluster
28%
Latent Tuberculosis Infection
28%
Hantavirus Pulmonary Syndrome
28%
Tuberculosis Diagnosis
28%
Maritime Canada
28%
Tonsillar Cancer
28%
Laser Plume
28%
Host Control
28%
Hospitalized Patients
28%
Surveillance Network
28%
Slow-release Oral Morphine
28%
Opioid Use Disorder
28%
Opioid Agonist Treatment
28%
Empetrum Nigrum
28%
Oxepine
28%
Human Leukocyte Antigen Class I
28%
HIV-1 Control
28%
Phomopsolides
28%
Human Immunodeficiency virus-1 Infection
28%
Immunization
28%
Vaccine Effectiveness
28%
Furanocoumarins
28%
Influenza Surveillance
28%
Surveillance Definitions
28%
Congenital Disorders of Glycosylation
28%
Serious Outcomes
28%
Fragaria Virginiana
28%
Decolonization
28%
Low Seroprevalence
28%
Injecting Equipment
28%
Alnus Incana
28%
Injection Drugs
28%
Canadian Medicinal Plant
28%
Clinical Severity
28%
California Serogroup Viruses
28%
Randomized Controlled Trial
28%
Streptococcus Zooepidemicus
28%
People Who Inject Drugs
28%
Hospitalization
28%
Klebsiella Oxytoca
28%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Influenza Vaccine
57%
Heracleum
57%
Vaccination Policy
50%
Antimycobacterial Agent
46%
Frailty
40%
Live Attenuated Influenza Vaccine
38%
Mycobacterium Tuberculosis
38%
Antimycobacterial
35%
Reinfection
33%
Staphylococcal Pneumonia
28%
Oxepine Derivative
28%
Pneumococcal Infection
28%
Streptococcal Pharyngitis
28%
Streptococcus pyogenes
28%
Furocoumarin
28%
Congenital Disorder of Glycosylation
28%
Alnus incana
28%
Aralia
28%
Alkyne Derivative
28%
Morphine
28%
Opiate
28%
Q Fever
28%
Klebsiella oxytoca
28%
Antimycobacterial Screening
28%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
28%
Chronic Hepatitis C
28%
Immunostimulant
28%
Respiratory Tract Disease
28%
Opiate Agonist
28%
Staphylococcal Bacteremia
28%
Peginterferon Alpha
28%
Granulomatous Amebic Encephalitis
28%
Miltefosine
28%
Voriconazole
28%
Acanthamoeba
28%
Medicinal Plant
28%
Hepatitis C
28%
Liver Disease
28%
Acorus Calamus
21%
Influenza A Virus (H1N1)
19%
Influenza A Virus (H3N2)
19%
Deoxypodophyllotoxin
17%
Betulin
17%
Fragaria
17%
Betulinic Acid
17%
Ursolic Acid
17%
Tonic Clonic Seizure
14%
Interferon
14%
Disease Exacerbation
14%
